Halberd Corporation: CORRECTION: Halberd Team Produces Peer Reviewed Article on Antibody Against Covid-19 Omicron Variant
JACKSON CENTER, PA / ACCESSWIRE / December 1, 2022 / Halberd Corporation's (OTC-PINK:HALB) Covid research has led to a scientific article titled, "A Novel Plant-Made Monoclonal Antibody Enhances the Synergetic
Mitchells Felder Kostenloser Wertpapierhandel Williama Hartman Halberd Corporation Novel Plant Made Monoclonal Antibody Enhances Synergetic Potency
Source: finanznachrichten.de